Literature DB >> 19047198

Skeletal muscle: not simply an organ for locomotion and energy storage.

Graeme I Lancaster1, Mark A Febbraio.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 19047198      PMCID： PMC2670074          DOI： 10.1113/jphysiol.2008.165753

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  12 in total

1.  Interleukins and exercise.

Authors:  M Gleeson
Journal:  J Physiol       Date:  2000-11-15       Impact factor: 5.182

2.  Humoral nature of the hypoglycemic factor of muscular work.

Authors:  M S GOLDSTEIN
Journal:  Diabetes       Date:  1961 May-Jun       Impact factor: 9.461

3.  Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans.

Authors:  Mark A Febbraio; Adam Steensberg; Charlotte Keller; Rebecca L Starkie; Henning B Nielsen; Peter Krustrup; Peter Ott; Niels H Secher; Bente K Pedersen
Journal:  J Physiol       Date:  2003-04-17       Impact factor: 5.182

4.  Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running.

Authors:  K Ostrowski; T Rohde; M Zacho; S Asp; B K Pedersen
Journal:  J Physiol       Date:  1998-05-01       Impact factor: 5.182

5.  Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans.

Authors:  R L Starkie; M J Arkinstall; I Koukoulas; J A Hawley; M A Febbraio
Journal:  J Physiol       Date:  2001-06-01       Impact factor: 5.182

6.  Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6.

Authors:  A Steensberg; G van Hall; T Osada; M Sacchetti; B Saltin; B Klarlund Pedersen
Journal:  J Physiol       Date:  2000-11-15       Impact factor: 5.182

Review 7.  Muscle as an endocrine organ: focus on muscle-derived interleukin-6.

Authors:  Bente K Pedersen; Mark A Febbraio
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

8.  Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity.

Authors:  Natalie Hiscock; M H Stanley Chan; Teresa Bisucci; Ian A Darby; Mark A Febbraio
Journal:  FASEB J       Date:  2004-04-01       Impact factor: 5.191

9.  Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction.

Authors:  Mark A Febbraio; Natalie Hiscock; Massimo Sacchetti; Christian P Fischer; Bente K Pedersen
Journal:  Diabetes       Date:  2004-07       Impact factor: 9.461

10.  Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise.

Authors:  Milena Penkowa; Charlotte Keller; Pernille Keller; Sune Jauffred; Bente Klarlund Pedersen
Journal:  FASEB J       Date:  2003-09-04       Impact factor: 5.191
View more
  4 in total

Review 1.  Metabolic interaction between purine nucleotide cycle and oxypurine cycle during skeletal muscle contraction of different intensities: a biochemical reappraisal.

Authors:  Piero L Ipata; Rossana Pesi
Journal:  Metabolomics       Date:  2018-02-27       Impact factor: 4.290

2.  CCL2 Gene Expression and Protein Level Changes Observed in Response to Wingate Anaerobic Test in High-Trained Athletes and Non-Trained Controls.

Authors:  Agnieszka Maciejewska-Skrendo; Maciej Tarnowski; Patrycja Kopytko; Andrzej Kochanowicz; Jan Mieszkowski; Błażej Stankiewicz; Marek Sawczuk
Journal:  Int J Environ Res Public Health       Date:  2022-08-12       Impact factor: 4.614

Review 3.  The role of triglyceride lipases in cancer associated cachexia.

Authors:  Suman K Das; Gerald Hoefler
Journal:  Trends Mol Med       Date:  2013-03-14       Impact factor: 11.951

4.  Land-based versus aquatic resistance therapeutic exercises for older women with sarcopenic obesity: study protocol for a randomised controlled trial.

Authors:  Karina Simone de Souza Vasconcelos; João Marcos Domingues Dias; Marília Caixeta de Araújo; Ana Cisalpino Pinheiro; Marcela Machado Maia; Rosângela Corrêa Dias
Journal:  Trials       Date:  2013-09-16       Impact factor: 2.279
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.